Dr Rajarshi Banerjee is CEO of Perspectum, which he co-founded in 2012, and now employs over 100 people in Oxford, Singapore and San Francisco.
Rajarshi has worked in the National Health Service since 2002, and trained in cardiology and internal medicine in London and Oxford. He developed the MR techniques for rapid non-invasive liver assessment in Oxford, and commercialized the method as LiverMultiScan, which is now FDA cleared and used in over 200 sites.
He graduated in medicine from Oxford, and went on to complete a Masters in Public Health in London before returning to Oxford for his doctorate. Dr Banerjee continues to work as a Consultant Physician with Oxford University Hospitals NHS Foundation Trust, with research into the phenotyping of liver disease at an individual and population level in adults and children. He has many years of experience in running clinical trials and working in multidisciplinary scientific teams to develop applications for cutting-edge imaging technology and is a keen advocate of smart trial design.
07:30 - 08:45
Inward Investment Global Growth – Opportunities and Challenges: USA
Sponsored by Penningtons Manches Cooper and James Cowper Kreston
In this session we will hear from investors from the US about why technology developed in Oxfordshire is attracting interest and investment from the US. We will also hear from Oxfordshire companies who have explored commercial opportunities in the US who want to share their experiences with those considering a similar path.
Confirmed Panellists: Rajarshi Banerjee – Perspectum Diagnostics, Rowan Gardner – Ozo Innovations, and Garry Muddyman – Conversis
Chaired by Sharon Bedford – James Cowper Kreston
Breakfast available from 07:00.
Director, Clusters and Harwell Campus Business Development, UKRI-STFC
Co-founder and Chief Scientific Offer, Oxford PV
Managing Director, Ricardo Energy & Environment
Managing Director, Oxford Instruments NanoScience